Acute Effect of Capsimax on Resistance Exercise Performance, Muscle Oxygenation, Nitric Oxide Release, Resting Energy Expenditure and Reaction Time

Part of paid clinical trials in Hempstead, New York.

Sponsor
Hofstra University
Study ID
NCT06612658
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • None Volunteer

Eligibility Criteria

Sex
MALE
Age
18 Years - 35 Years
Healthy Volunteers
Not accepted

Interventions

  • A novel, proprietary encapsulated form of Capsicum extract in beadlet form standardized to 2% capsaicinoids — DIETARY_SUPPLEMENT
    This study will investigate the effect of the supplement on exercise performance.

Study Details

Capsimax is a novel, proprietary encapsulated form of capsaicin, a natural and bioactive phytochemical found in chili pepper and other spicy food. The purpose of this study is to investigate the effect of Capsimax on resistance exercise performance, reaction time, and resting energy expenditure around exercise. This investigation will also measure muscle oxygenation and intramuscular nitric oxide in real time during resistance exercise using a non-invasive wearable technology. Primary Objective • To examine the effects of Capsimax on physical performance metrics including peak power and rate of force development during an isometric strength test and performance during the barbell back squat exercise protocol (e.g., repetitions performed, total volume, peak power, average power). Secondary Objectives * To examine the effects of Capsimax on resting energy expenditure around exercise. * To examine the effects of Capsimax on nitric oxide bioavailability and skeletal muscle oxygenation during exercise. Exploratory Objective • To examine the effects of Capsimax on reaction time around exercise

Key Dates

Start date
Oct 1, 2024
Status verified
Sep 2024
Primary completion
May 30, 2025
Completion
May 30, 2025

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER

Arms

  • Experimental: Capsimax
    Capsules containing either 100 mg Capsimax (OmniActive Health Technologies)
  • Placebo Comparator: Placebo
    Microcrystalline cellulose

Primary Outcome Measure

Resistance exercise performance [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Hofstra UniversityHempsteadNew York11549
Adam M Gonzalez, PhD
[email protected]
516-463-5224

Find similar trials in Hempstead, NY

By research site
Hofstra University· Hempstead, NY